In addition, the proportion of CXCL13+CD39+CD8+ TILs in pTRT cell-high BrM was similar to that in primary NSCLC, one of the most responsive cancers to ICB53. The gene discussed is ENTPD1; the disease is non-small cell lung carcinoma.